WorldCare Clinical Expands Globally with New Offices across Europe, S. America and Asia Pacific
WorldCare Clinical, LLC
(WCC), an imaging CRO focused on maximizing the precision and accuracy of independent assessments in clinical trials, today announced new locations in Brazil, Dubai, Poland, Spain, and Singapore.
In response to sponsors’ requests to provide site support in local time zones and languages, WorldCare Clinical has expanded its technical support capabilities by working with parent company WorldCare Limited’s physicians and coordinators who offer teleradiology and second opinion services.
“Our global infrastructure has been in place for over 20 years and is essential to our business model,” commented WorldCare Limited CEO Nasser Menhall. “We are delighted to provide this service on an as-needed basis to WorldCare Clinical.”
“WorldCare Clinical is excited to expand our ability to provide 24/7 technical support to global sites by working with a pre-existing network of physicians who are already experts in managing radiology and clinical data for independent review,” said Richard Walovitch, Ph.D., president of WorldCare Clinical. “In addition to now having offices in Brazil, Dubai, Poland, Spain and Singapore, we also have access to a network of representatives in Eastern and Western Europe, the Middle East and Asia Pacific to provide advanced technical support and training as needed.”
WCC’s WorldPRO data management platform captures and consolidates all data, including images, pathology slides, pictures of skin lesions, patient feedback, and more, and organizes data for a digital central review and streamlined submission to regulatory agencies. This unique solution facilitates fast turnaround time for reviews and presents data uniformly to multi-discipline reviewers to enable the first-ever completely digital central assessment of subjective endpoints for maximum regulatory impact. For both trials that include an imaging component and those that do not, WCC can execute a blinded independent central review (BICR) of any type of clinical data.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Making the Grade: Registries as Sources of Regulatory-Grade Real-World Evidence (RWE)
February 13th 2025Dr. Peter Wahl, MLA, MS, ScD, VP and Global Head of Scientific Affairs at CorEvitas, part of the PPD™ clinical research business of Thermo Fisher Scientific, discusses the critical role of protocol-driven registries in generating regulatory grade RWE to serve multiple and evolving evidence needs across the drug development life cycle. He covers key considerations for selecting the right type of registry, the advantages over EMR datasets, and how registry data contextualizes safety and effectiveness to fulfill FDA and EMA post-marketing requirements.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.
